Opening the door for HIF1α tuning

摘要

In this issue of Blood, Speth et al identify the beneficial effects of a pharmacologic stabilizer of hypoxia-inducible factor-1a (HIF1a) for the efficient trafficking of hematopoietic stem and progenitor cells (HSPCs) to the bone marrow niche.1